glp-1 neuroinflammation Drugs: For Multiple Chronic Conditions Neuroprotective Actions of Glucagon-Like Peptide-1

GLP (glucagon-like peptide-1) receptor agonists are part of a class of drugs that were initially created to help address type 2 diabetes but are also now used for weight management purposes

GIPR was first cloned in rats, identifying a 455-amino acid glycoprotein with a predicted molecular weight of approximately 59 kDa (41)

Check fasting glucose daily for the first 2 weeks after starting or increasing dose

There is currently no official contraindication to taking tirzepatide and orlistat together, as they work through completely different mechanisms and are not known to have direct pharmacological interactions